Skip to main content
Equibles

SHILPAMED · Shilpa Medicare Limited

Use SHILPAMED with AI

Add company filings, earnings and prices to ChatGPT or Claude, then ask questions in your own chat.

Choose your app for step-by-step connection instructions. Sign in with Equibles when asked; no code or API key is needed.

Claude ChatGPT

After connecting, ask your AI to use Equibles to research SHILPAMED.

Other apps & server URL
https://mcp.equibles.com/mcp
Gemini CLI setup
or ask here

Free, nothing to set up — ALVIS runs on the same tools and cites every figure.

See what you can ask in ChatGPT or Claude

All connection guides →
991.50 INR +1.85 (+0.19%) At close · Nov 13
Rebalance outlook locked
Market Cap
193.92B INR
Shares
195.58M
Volume · Nov 13 1.15M Avg daily vol (3M) 1.01M

Price & Indicators

Drag to pan · scroll to zoom
Indicators
Price
Panels
Event markers
20d MA 50d MA 200d MA Earnings Investor day
Close991.50 INR Open1,000.00 INR Day982.10–1,025.00 INR 52W close267.00–1,073.70 INR Avg vol 30d874K Last earningsNov 5, 2026 DataOct 2025–Nov 2026

Raw chart and full-history price indicators begin at the captured split on Oct 3, 2025; bars on opposite sides are not compared.

Latest documents

2026
Nov 5
Earnings call
Q2 FY27 revenue hits record Rs. 538 crore

Shilpa Medicare reported record Q2 FY27 revenue of Rs. 538 crore, up 35% year-on-year. First-half revenue was 1,007 crores and PAT was 180 crores.

3 source passages
welcome to the Shilpa Medicare Q2 FY27 results conference call. we have delivered our highest ever quarterly revenues with quarterly revenues of Rs. 538 crore, reflecting a robust growth of 35% year And revenue for the first half were 1,007 crores, growing at 44% year-on-year. Pat for the quarter was 79 crores and 180 crores for the first half of FY27. Open the document at this passage
All documents

Quarterly results

Revenue Net income Net loss
▲11.5% 3.19B INR 317.84M INR '25 Q3 ▲13.4% 3.31B INR 0 INR '25 Q4 ▲9.9% 3.21B INR 0 INR '26 Q1 ▲7.6% 3.70B INR 440.67M INR '26 Q2 ▲28.3% 4.10B INR 0 INR '26 Q3 ▲32.1% 4.37B INR 1.08B INR '26 Q4 ▲44.9% 4.66B INR 1.01B INR '27 Q1 LATEST ▲43% 5.29B INR 791.90M INR '27 Q2

Technicals

trend & momentum for long-term holders illustrative — not investment advice
Price context
position in its 52-week range
Range low 267.00 INR Now 991.50 INR · 90% Range high 1,073.70 INR
vs 200-day avg +61% vs 50-day avg +3%

Illustrative technical + ownership context — a signal mix, not investment advice.

Performance

Raw-price comparisons begin at the captured split on Oct 3, 2025; windows that need an earlier baseline remain unavailable.

5D 20D 120D MTD YTD
XNSE:SHILPAMED +5.2% +7.5% +102.2% +3.8% +208.7%

Exchange listing

Market
XNSE
Ticker
SHILPAMED
ISIN
INE790G01031
Security
Ordinary share
Trading currency
INR

Company

Website
https://www.vbshilpa.com/
Investor relations
https://vbshilpa.com/Disclosure-Regulation.php

Other listings of this company

Share classes and depositary receipts can have different prices and dividends.

Recent dividends

Ex-dividend dateAmount per share
2026-09-04 0.60 INR
2025-09-17 0.50 INR
2022-09-19 0.55 INR
2021-09-20 0.55 INR
2020-03-16 0.55 INR
2019-09-12 0.50 INR
2018-03-01 0.35 INR
2017-03-21 0.30 INR
2016-03-28 0.30 INR
2015-09-16 0.275 INR
2014-09-11 0.25 INR

Upcoming investor events

No upcoming investor events are listed for this company yet.

Earnings calls

  • Earnings call · Q2 2027 2026-11-05 Audio Transcript
    Earnings Call
  • Earnings call · Q1 2027 2026-08-05 Audio Transcript
    Earnings Call
  • Earnings call · Q4 2026 2026-05-22 Audio Transcript
    Earnings Call